These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35513495)

  • 41. Induction of antigen-specific unresponsiveness with synthetic peptides: specific immunotherapy for treatment of allergic and autoimmune conditions.
    Wraith DC
    Int Arch Allergy Immunol; 1995 Dec; 108(4):355-9. PubMed ID: 7580308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver sinusoidal endothelial cells: a new type of organ-resident antigen-presenting cell.
    Limmer A; Knolle PA
    Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 1():S7-11. PubMed ID: 11603871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Role of Viral Infections in the Onset of Autoimmune Diseases.
    Sundaresan B; Shirafkan F; Ripperger K; Rattay K
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies.
    Meffre E; O'Connor KC
    Immunol Rev; 2019 Nov; 292(1):90-101. PubMed ID: 31721234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanoparticle-based approaches to immune tolerance for the treatment of autoimmune diseases.
    Serra P; Santamaria P
    Eur J Immunol; 2018 May; 48(5):751-756. PubMed ID: 29427438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Application of oral tolerance to the treatment of autoimmune diseases--active suppression and bystander suppression].
    Matsui M
    Nihon Rinsho; 1997 Jun; 55(6):1537-42. PubMed ID: 9200945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.
    Weiner HL; Friedman A; Miller A; Khoury SJ; al-Sabbagh A; Santos L; Sayegh M; Nussenblatt RB; Trentham DE; Hafler DA
    Annu Rev Immunol; 1994; 12():809-37. PubMed ID: 8011298
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dendritic cells in tolerance induction for the treatment of autoimmune diseases.
    Rescigno M
    Eur J Immunol; 2010 Aug; 40(8):2119-23. PubMed ID: 20853497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.
    Hemon P; Renaudineau Y; Debant M; Le Goux N; Mukherjee S; Brooks W; Mignen O
    Clin Rev Allergy Immunol; 2017 Oct; 53(2):141-165. PubMed ID: 28500564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity.
    Bottazzo GF; Pujol-Borrell R; Hanafusa T; Feldmann M
    Lancet; 1983 Nov; 2(8359):1115-9. PubMed ID: 6138647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteasomal processing of nuclear autoantigens in systemic autoimmunity.
    Chen M; von Mikecz A
    Autoimmun Rev; 2005 Mar; 4(3):117-22. PubMed ID: 15823496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heat Shock Proteins Can Be Surrogate Autoantigens for Induction of Antigen Specific Therapeutic Tolerance in Rheumatoid Arthritis.
    van Eden W; Jansen MAA; Ludwig IS; Leufkens P; van der Goes MC; van Laar JM; Broere F
    Front Immunol; 2019; 10():279. PubMed ID: 30873163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver immunity, autoimmunity, and inborn errors of immunity.
    Parlar YE; Ayar SN; Cagdas D; Balaban YH
    World J Hepatol; 2023 Jan; 15(1):52-67. PubMed ID: 36744162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploiting Rational Assembly to Map Distinct Roles of Regulatory Cues during Autoimmune Therapy.
    Oakes RS; Tostanoski LH; Kapnick SM; Froimchuk E; Black SK; Zeng X; Jewell CM
    ACS Nano; 2021 Mar; 15(3):4305-4320. PubMed ID: 33645967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell mediated immune regulation in autoimmunity.
    Gillissen G; Pusztai-Markos Z
    Allergol Immunopathol (Madr); 1979; 7(2):153-68. PubMed ID: 313696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of antigen-specific tolerance through hematopoietic stem cell-mediated gene therapy: the future for therapy of autoimmune disease?
    Coleman MA; Steptoe RJ
    Autoimmun Rev; 2012 Dec; 12(2):195-203. PubMed ID: 23047179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance induction.
    Gharagozloo M; Majewski S; Foldvari M
    Nanomedicine; 2015 May; 11(4):1003-18. PubMed ID: 25596076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of autoimmune disease by oral tolerance to autoantigens.
    Whitacre CC; Gienapp IE; Meyer A; Cox KL; Javed N
    Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S31-9. PubMed ID: 8811061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms of autoimmunity in human diseases: a critical review of current dogma.
    Benson RA; Brewer JM; Platt AM
    Curr Opin Rheumatol; 2014 Mar; 26(2):197-203. PubMed ID: 24445477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune diseases.
    Streeter HB; Wraith DC
    Curr Opin Immunol; 2021 Jun; 70():75-81. PubMed ID: 33878516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.